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719 Gene transfection of hepatocyte growth factor attenuates the progression of
cardiac remodeling in the hypertrophied heart
Keiji Iwata, MD, Yoshiki Sawa, MD, Satoru Kitagawa-Sakakida, MD,
Naomasa Kawaguchi, MD, Nariaki Matsuura, MD, Toshikazu Nakamura, MD, and
Hikaru Matsuda, MD, Osaka, Japan
The overexpression of HGF significantly decreased the expression of TGF-1 and myocardial
collagen content, and attenuated the significant decrease in LV diastolic function in the rat heart
subjected to pressure overload. Thus, the transfection of the HGF gene into the hypertrophied
heart may be a strategy for the hypertrophied and failing heart.
General Thoracic
Surgery
(GTS)
726 Partial cricotracheal resection for pediatric subglottic stenosis: Long-term
outcome in 57 patients
Yves Jaquet, MD, Florian Lang, MD, Raphaelle Pilloud, MD, Marcel Savary, MD, and
Philippe Monnier, MD, Lausanne, Switzerland
Partial cricotracheal resection is indicated for the treatment of severe (grade III and IV)
subglottic stenosis in infants and children. This analysis of the long-term results of 57 patients
focuses on functional parameters, such as decannulation rates, breathing, and voice quality.
733 Computed tomographic images reflect the biologic behavior of small lung
adenocarcinoma: They correlate with cell proliferation,
microvascularization, cell adhesion, degradation of extracellular matrix, and
K-ras mutation
Boming Dong, MD, Masami Sato, MD, Akira Sakurada, MD, Motoyasu Sagawa, MD,
Chiaki Endo, MD, Shulin Wu, MD, Sumitaka Yamanaka, MD, Akira Horii, MD, and
Takashi Kondo, MD, Sendai, Natori, and Kanazawa, Japan
The computed tomographic image of small lung adenocarcinoma is correlated with biologic
activities and thus provides possible prognostic information.
740 Prognostic significance of dysadherin expression in patients with non–small
cell lung cancer
Masaya Tamura, MD, Yasuhiko Ohta, MD, Yoshio Tsunezuka, MD, Isao Matsumoto, MD,
Kazuyuki Kawakami, MD, Makoto Oda, MD, and Go Watanabe, MD, Kanazawa, Japan
Dysadherin expression is an independent prognostic factor in NSCLC. The overall survival of
patients with positive dysadherin and reduced E-cadherin expression was significantly worse
than that of patients with negative dysadherin and preserved E-cadherin expression (P 
.0002). Combined immunohistochemical analysis of dysadherin and E-cadherin expression
might provide further prognostic information.
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